A randomized controlled trial to evaluate the effectiveness of adjuvant chemotherapy using FOLFOX to prevent recurrence after curative radiofrequency ablation of liver metastasis from colorectal carcinoma
Not Applicable
- Conditions
- Cases with liver metastasis from colorectal carcinoma, which is removed curatively by radiofrequency ablation
- Registration Number
- JPRN-C000000360
- Lead Sponsor
- Department of gastroenterology, Tokyo University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 190
Inclusion Criteria
Not provided
Exclusion Criteria
The patients with other malignant disease, non-curative radiofrequency ablation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method